Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Sobanski

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
La Revue Du Praticien|November 10, 2009
[National ranking exam. Advice from a highly ranked student]Vincent Sobanski
The European Respiratory Journal|June 25, 2021
Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertensionDavid Launay, Sébastien Sanges, Vincent Sobanski
Current Opinion in Rheumatology|September 17, 2020
Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doorsVincent Sobanski, Alain Lescoat, David Launay
European Respiratory Review : an Official Journal of the European Respiratory Society|September 29, 2017
Pulmonary hypertension in systemic sclerosis: different phenotypesDavid Launay, Vincent Sobanski, Eric Hachulla, et al.
BMC Psychiatry|May 26, 2025
Can somatic symptom disorder be an iatrogenic disease?Mathilde Horn, Thomas Fovet, Vincent Sobanski, et al.
Current Rheumatology Reports|February 5, 2016
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Vincent Sobanski, David Launay, Eric Hachulla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2025
Absence of functional autoantibodies in systemic sclerosis: is now the right time to broaden reactome analysis? Comment on "Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis" published in Arthritis RheumatologyAurélien Chepy, Sylvain Dubucquoi, David Launay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
ReplyVincent Sobanski, Jonathan Giovannelli, Christopher P Denton, et al.
Journal of Translational Autoimmunity|February 7, 2025
Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic playersAurélien Chepy, Aurore Collet, David Launay, et al.
American Journal of Respiratory and Critical Care Medicine|May 17, 2013
Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strainsVincent Sobanski, Daniel Ajzenberg, Laurence Delhaes, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
La Revue Du Praticien|November 10, 2009
[National ranking exam. Advice from a highly ranked student]Vincent Sobanski
The European Respiratory Journal|June 25, 2021
Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertensionDavid Launay, Sébastien Sanges, Vincent Sobanski
Current Opinion in Rheumatology|September 17, 2020
Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doorsVincent Sobanski, Alain Lescoat, David Launay
European Respiratory Review : an Official Journal of the European Respiratory Society|September 29, 2017
Pulmonary hypertension in systemic sclerosis: different phenotypesDavid Launay, Vincent Sobanski, Eric Hachulla, et al.
BMC Psychiatry|May 26, 2025
Can somatic symptom disorder be an iatrogenic disease?Mathilde Horn, Thomas Fovet, Vincent Sobanski, et al.
Current Rheumatology Reports|February 5, 2016
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Vincent Sobanski, David Launay, Eric Hachulla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2025
Absence of functional autoantibodies in systemic sclerosis: is now the right time to broaden reactome analysis? Comment on "Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis" published in Arthritis RheumatologyAurélien Chepy, Sylvain Dubucquoi, David Launay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
ReplyVincent Sobanski, Jonathan Giovannelli, Christopher P Denton, et al.
Journal of Translational Autoimmunity|February 7, 2025
Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic playersAurélien Chepy, Aurore Collet, David Launay, et al.
American Journal of Respiratory and Critical Care Medicine|May 17, 2013
Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strainsVincent Sobanski, Daniel Ajzenberg, Laurence Delhaes, et al.
Pageof 8